Prospective multicenter study of the impact of oncotype DX colon cancer assay results on treatment recommendations in stage II colon cancer patients
about
Molecular predictive markers in tumors of the gastrointestinal tractGenetics and Genetic Biomarkers in Sporadic Colorectal CancerColorectal Carcinoma: A General Overview and Future Perspectives in Colorectal CancerA Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon CancerAdjuvant therapy for resected high-risk colon cancer: Current standards and controversiesComparative economics of a 12-gene assay for predicting risk of recurrence in stage II colon cancerMicrosatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis.Oncologists' Selection of Genetic and Molecular Testing in the Evolving Landscape of Stage II Colorectal Cancer.Biomarker-directed Targeted Therapy in Colorectal Cancer.Personalized treatment for patients with colorectal cancer: role of biomarkers.Current and future biomarkers in the treatment of colorectal cancer.Clinical impact of a 31-gene expression profile test for cutaneous melanoma in 156 prospectively and consecutively tested patients.The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: A prospective clinical utility assessment of the 12-gene DCIS score™ result.Recurrence-associated gene signature optimizes recurrence-free survival prediction of colorectal cancer.Clinicopathological, genomic and immunological factors in colorectal cancer prognosis.Clinical Application of Detecting 21-Gene Recurrence Score in Predicating Prognosis and Therapy Response of Patients with Breast Cancer from Two Medical Centers.Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study.Prospective Evaluation of a 12-Gene Assay on Patient Treatment Decisions and Physician Confidence in Mismatch Repair Proficient Stage IIA Colon Cancer.Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity.Microsatellite Instability Pathway and EMAST in Colorectal Cancer.Are Gene Signatures Ready for Use in the Selection of Patients for Adjuvant Treatment?
P2860
Q28070583-6507EBBD-589E-4A4F-8E86-88E835CF4B9DQ28084346-758A1734-8292-4DB2-89AC-6AC84EB10571Q30238915-B8B8CB2E-0B4B-4487-A512-FB42FDED0720Q33776664-9A98C426-F994-4A1A-BA33-033E61B516A2Q34368278-C6C8A5FD-FBA9-4924-AF45-7DC801801321Q34573853-F86EC6C6-E185-4295-AEEA-690C3C85FDF7Q36730670-E2BBB7C1-990A-48BB-8986-24BCDA307F65Q37125051-363C9C7F-E8F5-405F-8CA6-A8E0E601C05FQ38383343-162F3129-CFBE-4122-8A6D-771F36156B2FQ38390834-E6DFA873-B6CE-4000-A01D-F8FED3287ABFQ38787244-7FBF8E06-F14E-48A8-83AE-809D777250FAQ39746034-5FAD2A95-E0ED-435F-9A39-C59840F560D7Q40882141-7172E111-F229-4E68-A679-6560A3F3731FQ47110810-867B5A74-901F-4C06-876F-918A260DBA0DQ47728264-142B9C4C-0AFE-48C3-B2F1-8F4F9F4FD236Q48110842-205E45E4-A6A6-4482-A160-7D37F9FD5B26Q48265163-4ED77157-D92E-49C6-8AB1-F976AF2FC170Q50489243-77AEE838-C7E3-4DC3-9001-7043E43A573FQ52649614-63089302-5B8B-4D06-9072-DF8E94FD3393Q53698643-C178623A-F050-4E62-8196-213A1236B4A5Q58053523-935692E0-3857-4BEC-BD6D-CA3B9815E553
P2860
Prospective multicenter study of the impact of oncotype DX colon cancer assay results on treatment recommendations in stage II colon cancer patients
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prospective multicenter study ...... stage II colon cancer patients
@ast
Prospective multicenter study ...... stage II colon cancer patients
@en
Prospective multicenter study ...... tage II colon cancer patients.
@nl
type
label
Prospective multicenter study ...... stage II colon cancer patients
@ast
Prospective multicenter study ...... stage II colon cancer patients
@en
Prospective multicenter study ...... tage II colon cancer patients.
@nl
prefLabel
Prospective multicenter study ...... stage II colon cancer patients
@ast
Prospective multicenter study ...... stage II colon cancer patients
@en
Prospective multicenter study ...... tage II colon cancer patients.
@nl
P2093
P2860
P1433
P1476
Prospective multicenter study ...... stage II colon cancer patients
@en
P2093
Calvin Chao
Gamini S Soori
Geetika Srivastava
George Kim
J Philip Kuebler
Lindsay A Renfro
Margarita Lopatin
Miroslaw Mazurczak
Rex B Mowat
P2860
P304
P356
10.1634/THEONCOLOGIST.2013-0401
P577
2014-04-07T00:00:00Z